Samarth Kulkarni Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Samarth Kulkarni is Chief Executive Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 171,613 shares of CRSP, which is worth approximately $7.99 Million. The most recent transaction as insider was on Apr 19, 2017, when has been sold 7,258 shares (Common Shares) at a price of $1.81 per share, resulting in proceeds of $13,137. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K
12.68% 3M change
11.66% 12M change
Total Value Held $7.99 Million

Samarth Kulkarni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 19 2017
BUY
Exercise of conversion of derivative security
$13,137 $1.81 p/Share
7,258 Added 4.89%
141,305 Common Shares

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
CNTA
Centessa Pharmaceuticals plc Healthcare
Director
SK

Samarth Kulkarni

Chief Executive Officer
Boston, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP